AstraZeneca and Johnson & Johnson have restarted their late-stage trials after finding that serious illnesses in a few volunteers appeared not to be related to the vaccines.
from Health https://ift.tt/3mkh81Q
October 24, 2020
Rose
Health, Health - The New York Times
No comments
Related Posts:
Old Dogs, New Research and the Secrets of AgingThe ways that dogs grow and age may provide potentially useful similarities with people. from Health https://ift.tt/3kd67ht … Read More
Is the Pfizer vaccine safe?So far Pfizer and BioNTech have reported no serious safety concerns from their vaccine. Before running the current large-scale study, the companies ran smaller clinical trials starting in May that were specifically designed t… Read More
‘Stand by Her’: In China, a Movement Hands Out Free Sanitary Pads in SchoolsStudents and teachers are placing pads outside bathrooms as part of a grass-roots campaign to fight period poverty and to remove the stigma surrounding menstruation. from Health https://ift.tt/32rogSQ … Read More
Who will get the new vaccine first?Pfizer’s chief executive has said that it could have 30 to 40 million doses of the vaccine before the end of the year, enough for 15 to 20 million people to get an initial shot and a booster three weeks later. from Health ht… Read More
Build Mental Endurance Like a ProAthletes who have endured the most grueling tests have a lot to tell us about how to thrive in the pandemic. from Health https://ift.tt/32qTc5z … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment